These observations suggest that the elevated circulating IL-36 in HCC patients mainly originates from circulating CD4+ T helper and CD8+ cytotoxic T cells, rather than from intrahepatic lymphocytes and/or hepatocytes. The gene discussed is CD4; the disease is hepatocellular carcinoma.